NC

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+14.09%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$5.28B
AUM Growth
+$532M
Cap. Flow
-$72.3M
Cap. Flow %
-1.37%
Top 10 Hldgs %
19.68%
Holding
239
New
18
Increased
58
Reduced
100
Closed
12
Avg Time Held
3.6 years
Top 10 Avg Time Held
2.4 years
Top 20 Avg Time Held
2.7 years

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$30.6M
2
VNT icon
Vontier
VNT
+$15.3M
3
FHN icon
First Horizon
FHN
+$14.8M
4
CFG icon
Citizens Financial Group
CFG
+$13.9M
5
TDY icon
Teledyne Technologies
TDY
+$11.3M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$33.1M
2
XLNX
Xilinx Inc
XLNX
+$27.2M
3
TMO icon
Thermo Fisher Scientific
TMO
+$26M
4
BALL icon
Ball Corp
BALL
+$16.2M
5
KNGT
KNIGHT TRANSPORTATION INC
KNGT
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 19.08%
3 Financials 14.32%
4 Consumer Discretionary 12.45%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MSFT icon
1
Microsoft
MSFT
$3.96T
$161M 3.05%
723,360
-300
-0% -$64.5K
2013 Q2
30 quarters
AAPL icon
2
Apple
AAPL
$5.01T
$161M 3.04%
1,211,230
-1,308
-0.1% -$157K
2016 Q1
19 quarters
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.2T
$125M 2.38%
1,432,100
-2,400
-0.2% -$202K
2016 Q4
16 quarters
V icon
4
Visa
V
$735B
$91M 1.72%
416,260
– –
2016 Q3
17 quarters
CTAS icon
5
Cintas
CTAS
$82.8B
$89.9M 1.7%
1,017,520
– –
2016 Q4
16 quarters
AON icon
6
Aon
AON
$58.4B
$87.9M 1.67%
416,255
-60,535
-13% -$12.4M
2013 Q2
30 quarters
TMO icon
7
Thermo Fisher Scientific
TMO
$249B
$83.8M 1.59%
179,924
-55,465
-24% -$26M
2013 Q2
30 quarters
ORLY icon
8
O'Reilly Automotive
ORLY
$70.1B
$82.8M 1.57%
2,745,465
– –
2013 Q2
30 quarters
HD icon
9
Home Depot
HD
$295B
$79.5M 1.5%
299,215
-290
-0.1% -$79.7K
2016 Q4
16 quarters
CBRE icon
10
CBRE Group
CBRE
$37.3B
$77.6M 1.47%
1,236,630
-202,970
-14% -$11.5M
2013 Q2
30 quarters
SWKS icon
11
Skyworks Solutions
SWKS
$18.1B
$72.1M 1.36%
471,355
-80
-0% -$11.7K
2015 Q4
20 quarters
AMZN icon
12
Amazon
AMZN
$2.74T
$68.6M 1.3%
421,300
-10,000
-2% -$1.6M
2017 Q1
15 quarters
FAST icon
13
Fastenal
FAST
$59.7B
$67.7M 1.28%
2,774,480
-61,740
-2% -$1.45M
2013 Q2
30 quarters
TJX icon
14
TJX Companies
TJX
$157B
$67M 1.27%
981,105
-1,690
-0.2% -$103K
2017 Q4
12 quarters
MDT icon
15
Medtronic
MDT
$121B
$65.7M 1.24%
560,820
-800
-0.1% -$88.1K
2016 Q3
17 quarters
GPN icon
16
Global Payments
GPN
$21.4B
$65.6M 1.24%
304,749
-10,552
-3% -$1.97M
2015 Q1
23 quarters
MA icon
17
Mastercard
MA
$528B
$64.7M 1.22%
181,165
– –
2013 Q2
30 quarters
HON icon
18
Honeywell
HON
$65.8B
$63.6M 1.2%
317,181
– –
2018 Q1
11 quarters
SCHW icon
19
Charles Schwab
SCHW
$167B
$63.4M 1.2%
1,194,555
-1,000
-0.1% -$45.3K
2016 Q3
17 quarters
CSCO icon
20
Cisco
CSCO
$448B
$62.5M 1.18%
1,397,300
-1,500
-0.1% -$61.6K
2016 Q3
17 quarters
LH icon
21
Labcorp
LH
$25.7B
$62.2M 1.18%
355,643
– –
2016 Q1
19 quarters
SBUX icon
22
Starbucks
SBUX
$106B
$61.7M 1.17%
576,775
– –
2014 Q4
24 quarters
FTV icon
23
Fortive
FTV
$17.3B
$61.2M 1.16%
1,147,649
-223,792
-16% -$11.5M
2016 Q3
17 quarters
JPM icon
24
JPMorgan Chase
JPM
$890B
$59.8M 1.13%
470,245
-600
-0.1% -$67.1K
2018 Q3
9 quarters
CPRT icon
25
Copart
CPRT
$24.3B
$58.2M 1.1%
1,829,620
-200,720
-10% -$5.85M
2013 Q2
30 quarters
1
2 3 4 5

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q4 2020 Portfolio in Review

As of Q4 2020, Nicholas Company held 239 positions worth $5.28B, up 11% from $4.75B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Company's Q4 2020 filing shows 18 new, 58 increased, 100 reduced and 12 closed positions. Its largest new stake was DexCom: 343,120 shares worth $31.7M. The largest sale was Pfizer, an estimated $33.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Nicholas Company's largest Q4 2020 buy was DexCom: 343,120 shares worth $31.7M.
  • Nicholas Company added most to First Horizon in Q4 2020, an estimated $14.8M increase.
  • Nicholas Company's biggest Q4 2020 reduction was Xilinx Inc, cutting an estimated $27.2M.
  • Nicholas Company fully exited Pfizer in Q4 2020, selling an estimated $33.1M.
  • Nicholas Company's ten largest holdings make up 20% of its $5.28B portfolio in Q4 2020.
  • Nicholas Company opened 18 new positions and closed 12 in Q4 2020.
  • Nicholas Company's portfolio value rose 11% quarter-over-quarter to $5.28B.

Based on Nicholas Company's 13F filing for Q4 2020, filed 10 Feb 2021.